Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date November 03, 2009 · Filed November 04, 2009
Section 16 reporting ended · disclosed 2009-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 1
1 source rowRow 1 · 2009-11-03 · Disposition to issuer · Disposed 31,749.77 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. |
| Stock Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2009-11-03 · Disposition to issuer · Disposed 71,569.81 · Balance 0 F2: Each unit is the economic equivalent of one share of common stock. F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. |
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2009-11-03 · Disposition to issuer · Disposed 5,930.43 · Balance 0 F2: Each unit is the economic equivalent of one share of common stock. F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
F2: Each unit is the economic equivalent of one share of common stock.
F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2009 Filed Nov 4, 2009 22:57 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerStock Units · Derivative | 5,930.43 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051076 · c91876_4x0.xml · derivative · entry 3 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,930.43 shares Expires not disclosed F2 · derivative.exercise_price: Each unit is the economic equivalent of one share of common stock. F3 · price: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. F3 · derivative.exercise_date: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. F3 · derivative.expiration_date: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:57 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerStock Equivalent Units · Derivative | 71,569.81 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051076 · c91876_4x0.xml · derivative · entry 2 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 71,569.81 shares Expires not disclosed F2 · derivative.exercise_price: Each unit is the economic equivalent of one share of common stock. F3 · price: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. F3 · derivative.exercise_date: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. F3 · derivative.expiration_date: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:57 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerCommon Shares | 31,749.77 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051076 · c91876_4x0.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| June 01, 2009 Filed Jun 2, 2009 17:01 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-09-000081 · van744.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,687.5 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. F3 · balance_after: Includes shares acquired under the Bank of New York Mellon Systematic Investment Program for Schering-Plough Corporation Common Stock through May 26, 2009. Read SEC document |
| December 01, 2008 Filed Dec 1, 2008 23:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 2,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000105 · van695.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,950.47 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. F3 · balance_after: Includes shares acquired under the Bank of New York Mellon Systematic Investment Program for Schering-Plough Corporation through November 25, 2008. Read SEC document |
| May 30, 2008 Filed May 30, 2008 21:31 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000068 · van681.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,210.04 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. F3 · balance_after: Includes shares acquired under the Bank of New York Systematic Investment Program for Schering-Plough Corporation Common Stock through May 27, 2008. Read SEC document |
| December 01, 2007 Filed Dec 4, 2007 21:56 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-07-000091 · van637.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,394.1 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. F3 · balance_after: Includes shares acquired under the Bank of New York Systematic Investment Program for Schering-Plough Corporation Common Stock through November 27, 2007. Read SEC document |
| June 01, 2007 Filed Jun 5, 2007 19:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,018 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-07-000066 · van629.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,240.88 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. F3 · balance_after: Includes shares acquired under the Bank of New York Systematic Investment Program for Schering-Plough Corporation Common Stock through May 29, 2007. Read SEC document |
| December 01, 2006 Filed Dec 5, 2006 16:57 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000150 · van592.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,091.16 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. F3 · balance_after: Includes shares acquired under the Bank of New York Systematic Investment Program for Schering-Plough Corporation Common Stock through November 30, 2006. Read SEC document |
| June 01, 2006 Filed Jun 5, 2006 19:46 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,748 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000093 · van560.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,501.32 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| May 20, 2006 Filed May 23, 2006 20:02 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000067 · van550.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,753.32 F1 · price: Not Applicable. F2 · balance_after: Includes shares acquired under the Bank of New York Systematic Investment Program for Schering-Plough Corporation Common Stock through February 28, 2006. Read SEC document |
| January 01, 2006 Filed Jan 4, 2006 17:56 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,199.04 | $20.85 | $24,999.98 |
DisclosureSEC source: 0000310158-06-000003 · van516.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,629.54 Underlying: Common Shares · 1,199.04 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 30, 2005. Read SEC document |
| April 27, 2005 Filed Apr 29, 2005 19:30 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000044 · van470.xml · nonDerivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,618.75 F1 · price: Not Applicable. F2 · balance_after: Includes shares acquired under the Bank of New York Systematic Investment Program for Schering-Plough Corporation Common Stock through February 28, 2005. Read SEC document |
| January 01, 2005 Filed Jan 4, 2005 19:49 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,197.32 | $20.88 Strike: $0.00 | $25,000.04 |
DisclosureSEC source: 0001223203-05-000021 · van444.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,758.97 Underlying: Common Shares · 1,197.32 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 30, 2004. Read SEC document |
| October 01, 2004 Filed Oct 1, 2004 22:06 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,187.34 | $18.95 Strike: $0.00 | $22,500.09 |
DisclosureSEC source: 0000310158-04-000097 · van432.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,380.87 Underlying: Common Shares · 1,187.34 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 31, 2004. Read SEC document |
| September 28, 2004 Filed Sep 29, 2004 16:42 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 455.82 | $18.65 Strike: $0.00 | $8,501.04 |
DisclosureSEC source: 0000310158-04-000093 · van428.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,193.53 Underlying: Common Shares · 455.82 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes 170.00 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 31, 2004. Read SEC document |
| July 01, 2004 Filed Jul 1, 2004 22:37 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,244.47 | $18.08 Strike: $0.00 | $22,500.02 |
DisclosureSEC source: 0000310158-04-000085 · van422.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,567.71 Underlying: Common Shares · 1,244.47 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes 181.56 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 28, 2004. Read SEC document |
| April 28, 2004 Filed Apr 29, 2004 21:31 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 3,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000075 · van404.xml · derivative · entry 3 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,568.84 Underlying: Common Shares · 3,000 shares Expires not disclosed F7 · security: The stock units were credited pursuant to a deferral feature of the Directors Stock Award Plan. F8 · derivative.exercise_price: Not Applicable. F10 · price: Not Applicable. F9 · derivative.exercise_date: The stock units will be paid in shares of stock on dates selected in accordance with the Plan. F8 · derivative.expiration_date: Not Applicable. F11 · balance_after: Includes 45.36 shares acquired pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan, through February 26, 2004. These stock units were credited pursuant to a deferral feature of the Plan and will be paid in shares of stock on dates selected in accordance with the Plan. Read SEC document |
| April 27, 2004 Filed Apr 29, 2004 21:31 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 175.14 | $17.13 Strike: $0.00 | $3,000.15 |
DisclosureSEC source: 0000310158-04-000075 · van404.xml · derivative · entry 2 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,141.68 Underlying: Common Shares · 175.14 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1 F3 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F6 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of February 26, 2004. Read SEC document |
| April 21, 2004 Filed Apr 22, 2004 18:27 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 58.62 | $17.06 Strike: $0.00 | $1,000.06 |
DisclosureSEC source: 0000310158-04-000065 · van400.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,966.54 Underlying: Common Shares · 58.62 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of February 26, 2004. Read SEC document |
| April 01, 2004 Filed Apr 2, 2004 16:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 592.71 | $16.45 Strike: $0.00 | $9,750.08 |
DisclosureSEC source: 0000310158-04-000056 · van385.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,907.92 Underlying: Common Shares · 592.71 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes 167.59 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of February 26, 2004. Read SEC document |
| February 24, 2004 Filed Feb 25, 2004 16:06 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 165.75 | $18.10 Strike: $0.00 | $3,000.08 |
DisclosureSEC source: 0000310158-04-000035 · van354.xml · derivative · entry 2 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,147.62 Underlying: Common Shares · 165.75 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 16:06 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 164.85 | $18.20 Strike: $0.00 | $3,000.27 |
DisclosureSEC source: 0000310158-04-000035 · van354.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,981.87 Underlying: Common Shares · 164.85 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| February 18, 2004 Filed Feb 19, 2004 15:36 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 54.05 | $18.50 Strike: $0.00 | $999.93 |
DisclosureSEC source: 0000310158-04-000030 · van360.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,817.02 Underlying: Common Shares · 54.05 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 23:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 339.18 | $17.69 Strike: $0.00 | $6,000.09 |
DisclosureSEC source: 0000310158-04-000023 · van330.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,762.97 Underlying: Common Shares · 339.18 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| January 23, 2004 Filed Jan 23, 2004 22:49 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 57.08 | $17.52 Strike: $0.00 | $1,000.04 |
DisclosureSEC source: 0000310158-04-000018 · van324.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,423.79 Underlying: Common Shares · 57.08 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| January 14, 2004 Filed Jan 14, 2004 22:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 55.49 | $18.02 Strike: $0.00 | $999.93 |
DisclosureSEC source: 0000310158-04-000016 · van322.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,366.71 Underlying: Common Shares · 55.49 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Include shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| January 02, 2004 Filed Jan 5, 2004 23:39 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 550.85 | $17.70 Strike: $0.00 | $9,750.05 |
DisclosureSEC source: 0000310158-04-000014 · van318.xml · derivative · entry 2 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,311.22 Underlying: Common Shares · 550.85 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F6 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| January 01, 2004 Filed Jan 5, 2004 23:39 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,437.61 | $17.39 Strike: $0.00 | $25,000.04 |
DisclosureSEC source: 0000310158-04-000014 · van318.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,760.37 Underlying: Common Shares · 1,437.61 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| December 17, 2003 Filed Dec 18, 2003 14:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 59.52 | $16.80 Strike: $0.00 | $999.94 |
DisclosureSEC source: 0000310158-03-000156 · van309.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,322.76 Underlying: Common Shares · 59.52 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 00:01 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 180.39 | $16.63 Strike: $0.00 | $2,999.89 |
DisclosureSEC source: 0000310158-03-000138 · van297.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,263.24 Underlying: Common Shares · 180.39 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes 184.33 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 26, 2003. Read SEC document |
| November 21, 2003 Filed Nov 25, 2003 14:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 65.7 | $15.22 Strike: $0.00 | $999.95 |
DisclosureSEC source: 0000310158-03-000130 · van286.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,898.52 Underlying: Common Shares · 65.7 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| November 07, 2003 Filed Nov 12, 2003 15:07 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 66.45 | $15.05 Strike: $0.00 | $1,000.07 |
DisclosureSEC source: 0000310158-03-000110 · van271.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,832.82 Underlying: Common Shares · 66.45 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| October 28, 2003 Filed Oct 29, 2003 21:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 198.42 | $15.12 Strike: $0.00 | $3,000.11 |
DisclosureSEC source: 0000310158-03-000096 · van237.xml · derivative · entry 2 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,766.37 Underlying: Common Shares · 198.42 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| October 27, 2003 Filed Oct 29, 2003 21:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 196.98 | $15.23 Strike: $0.00 | $3,000.01 |
DisclosureSEC source: 0000310158-03-000096 · van237.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,567.95 Underlying: Common Shares · 196.98 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. Read SEC document |
| October 21, 2003 Filed Oct 23, 2003 13:27 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 62.5 | $16.00 Strike: $0.00 | $1,000.00 |
DisclosureSEC source: 0000310158-03-000091 · van228.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,370.97 Underlying: Common Shares · 62.5 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| October 01, 2003 Filed Oct 2, 2003 16:42 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 615.14 | $15.85 Strike: $0.00 | $9,749.97 |
DisclosureSEC source: 0000310158-03-000084 · van225.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,308.47 Underlying: Common Shares · 615.14 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| September 23, 2003 Filed Sep 24, 2003 22:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 305.8 | $16.35 Strike: $0.00 | $4,999.83 |
DisclosureSEC source: 0000310158-03-000078 · van220.xml · derivative · entry 2 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,693.33 Underlying: Common Shares · 305.8 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include 561.20 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| September 22, 2003 Filed Sep 24, 2003 22:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 61.39 | $16.29 Strike: $0.00 | $1,000.04 |
DisclosureSEC source: 0000310158-03-000078 · van220.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,387.53 Underlying: Common Shares · 61.39 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. Read SEC document |
| August 21, 2003 Filed Aug 22, 2003 20:07 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 60.68 | $16.48 Strike: $0.00 | $1,000.01 |
DisclosureSEC source: 0000310158-03-000069 · van213.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,764.94 Underlying: Common Shares · 60.68 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| August 14, 2003 Filed Aug 15, 2003 21:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 62.27 | $16.06 Strike: $0.00 | $1,000.06 |
DisclosureSEC source: 0000310158-03-000063 · van207.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,704.26 Underlying: Common Shares · 62.27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 30, 2003 Filed Aug 1, 2003 15:23 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 58.31 | $17.15 Strike: $0.00 | $1,000.02 |
DisclosureSEC source: 0000310158-03-000054 · van181.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,641.99 Underlying: Common Shares · 58.31 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 22, 2003 Filed Jul 23, 2003 21:26 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 58.93 | $16.97 Strike: $0.00 | $1,000.04 |
DisclosureSEC source: 0000310158-03-000047 · van159.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,583.68 Underlying: Common Shares · 58.93 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 10, 2003 Filed Jul 14, 2003 18:22 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 58.14 | $17.20 Strike: $0.00 | $1,000.01 |
DisclosureSEC source: 0000310158-03-000039 · van115.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,524.75 Underlying: Common Shares · 58.14 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 02, 2003 Filed Jul 2, 2003 22:14 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 51.68 | $19.35 Strike: $0.00 | $1,000.01 |
DisclosureSEC source: 0000310158-03-000034 · van99.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,466.61 Underlying: Common Shares · 51.68 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 12:56 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 513.16 | $19.00 Strike: $0.00 | $9,750.04 |
DisclosureSEC source: 0000310158-03-000031 · van93.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,414.93 Underlying: Common Shares · 513.16 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| June 24, 2003 Filed Jun 25, 2003 22:22 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 157.8 | $19.01 Strike: $0.00 | $2,999.78 |
DisclosureSEC source: 0000310158-03-000026 · van79.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,901.77 Underlying: Common Shares · 157.8 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| June 23, 2003 Filed Jun 25, 2003 19:18 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 104.82 | $19.08 Strike: $0.00 | $1,999.97 |
DisclosureSEC source: 0000310158-03-000021 · van74.xml · derivative · entry 1 VAN OORDT ROBERT FW · CIK 0001023222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,743.97 Underlying: Common Shares · 104.82 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.